Xiang Wang

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Signaling Pathway

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Jiajia Mo, Peng Zhou, Zhaoxing Chu, Yan Zhao, Xiang Wang
Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Meng-Yu Zuo, Tong-Juan Tang, Xiang Wang, Jin-Fan Gu, Liang Wang, Jian Chen, Juan Yao, Xiang-Yang Li, Peng Zhou, Jin-Ling Huang
Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)